Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
CC transcript
|
|
PALISADE BIO, INC. (CUR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Altium Capital Management LP reports a 0% stake in Palisade Bio, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.7% stake in Palisade Bio, Inc. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 5% stake in Palisade Bio, Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 1.4% stake in Palisade Bio, Inc. |
| 01/29/2021 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 6.4% stake in Seneca Biopharma, Inc. |
| 01/08/2021 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 4.5% stake in Seneca Biopharma Inc. |
| 02/11/2020 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Seneca Biopharma, Inc. |
| 02/07/2020 |
SC 13G/A
| Hudson Bay Capital Management LP reports a 10% stake in Seneca Biopharma, Inc. |
| 01/21/2020 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 9.9% stake in Seneca Biopharma Inc. |
| 02/14/2019 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 5% stake in Neuralstem, Inc. |
| 01/07/2019 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 8.6% stake in Neuralstem, Inc. |
| 02/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| PUTNAM INVESTMENTS LLC reports a 1.1% stake in NEURALSTEM INC |
| 02/16/2016 |
SC 13G/A
| PUTNAM INVESTMENTS LLC reports a 6.3% stake in NEURALSTEM INC |
| 09/12/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
|
|